This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Heraeus Precious Metals Gmbh & Co. Kg, Medac Gesellschaft Fur Klinische Spezialpraparate Mbh. Active years: 2014-2016.
Company Filing History:
2 out of 61 
1 out of 17 Years Active: 2014-2016
Title: Sascha Weiser: Innovator in Pharmaceutical Chemistry
Introduction
Sascha Weiser is a notable inventor based in Maintal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of stable crystalline forms of important compounds. With a total of 3 patents to his name, Weiser's work has the potential to impact the medical industry positively.
Latest Patents
One of Weiser's latest patents is focused on crystalline 4'-epidaunorubicin hydrochloride. This compound is provided in a crystalline form that is both stable and readily soluble. The process of producing this crystalline form involves crystallizing 4'-epidaunorubicin hydrochloride in a solvent system that includes various solvents. This innovative method not only enhances the stability of the compound but also facilitates its use in producing anthracyclines, which are vital in cancer treatment.
Career Highlights
Throughout his career, Sascha Weiser has worked with prominent companies such as Heraeus Precious Metals GmbH & Co. KG and Medac Gesellschaft für Klinische Spezialpräparate mbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceutical development.
Collaborations
Weiser has collaborated with notable professionals in his field, including Andrew Lupton and Holger Bindernagel. These partnerships have fostered an environment of innovation and have led to the advancement of various projects in pharmaceutical chemistry.
Conclusion
Sascha Weiser's contributions to the field of pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in the industry.